Literature DB >> 21074269

Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.

Jun Qian1, Zhen Qian, Jiang Lin, Dong-ming Yao, Qin Chen, Yun Li, Run-bi Ji, Jing Yang, Gao-fei Xiao, Ya-li Wang.   

Abstract

The epigenetic disturbances are recognized as an alternative mechanism contributing to the pathogenesis of acute myeloid leukemia (AML). GTPase regulator associated with focal adhesion kinase (GRAF), a putative tumor suppressor gene, was revealed with mutations and promoter methylation in AML and myelodysplastic syndrome. In this study, we investigated the methylation status of GRAF promoter in Chinese AML patients. Aberrant methylation of GRAF promoter was detected in 66.7% (88/132) of the cases analyzed. The methylation of GRAF gene could be detected in all FAB subtypes and in all cytogenetic risk groups. There were no significant differences in clinical features, FAB subtypes and cytogenetic risk groups between patients with and without GRAF methylation. GRAF transcript was significantly lower in AML group compared to controls (3.30 vs 56.06, P<0.001). Both patients with methylated GRAF gene and those without methylated GRAF gene had significantly lower GRAF transcript than controls (P<0.001). Furthermore, GRAF transcript was significantly lower in patients with methylated GRAF than those without methylated GRAF (1.64 vs 6.42, P=0.005). These findings suggest that the hypermethylation of GRAF promoter might be one of early events in the development of AML.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074269     DOI: 10.1016/j.leukres.2010.10.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

Review 1.  Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy.

Authors:  Nicola Rath; Michael F Olson
Journal:  EMBO Rep       Date:  2012-09-11       Impact factor: 8.807

Review 2.  The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis.

Authors:  Danjie Jiang; Qingxiao Hong; Yusheng Shen; Yan Xu; Huangkai Zhu; Yirun Li; Chunjing Xu; Guifang Ouyang; Shiwei Duan
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

3.  GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions.

Authors:  Safa Lucken-Ardjomande Häsler; Yvonne Vallis; Helen E Jolin; Andrew N McKenzie; Harvey T McMahon
Journal:  J Cell Sci       Date:  2014-09-04       Impact factor: 5.285

4.  Involvement of Rho GAP GRAF1 in maintenance of epithelial phenotype.

Authors:  Miriam Regev; Helena Sabanay; Elena Kartvelishvily; Zvi Kam; Alexander D Bershadsky
Journal:  Cell Adh Migr       Date:  2016-09-02       Impact factor: 3.405

Review 5.  The role of GTPase-activating protein ARHGAP26 in human cancers.

Authors:  Lingye Zhang; Anni Zhou; Shengtao Zhu; Li Min; Si Liu; Peng Li; Shutian Zhang
Journal:  Mol Cell Biochem       Date:  2021-10-30       Impact factor: 3.396

6.  Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.

Authors:  Agnieszka Dzikiewicz-Krawczyk; Anna Macieja; Ewa Mały; Danuta Januszkiewicz-Lewandowska; Maria Mosor; Marta Fichna; Ewa Strauss; Jerzy Nowak
Journal:  J Hematol Oncol       Date:  2014-06-02       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.